Longitudinal trends in antibiotic resistance of Escherichia coli: A 10-years retrospective analysis in a tertiary care hospital in Lahore, Pakistan

巴基斯坦拉合尔一家三级医院对大肠杆菌抗生素耐药性的10年回顾性分析:纵向趋势研究

阅读:4

Abstract

OBJECTIVE: In Pakistan, the rising rate of Escherichia coli (E. coli) resistance has been reported, leading to limited treatment options and contributing to a high morbidity and mortality ratio. This study aimed to analyze changes in antibiotic resistance patterns against commonly prescribed antibiotics in a tertiary care hospital in Lahore, Pakistan, over the span of 10 years. METHODOLOGY: A retrospective cross-sectional study was designed to analyze a decade-long (2013-2022) resistance trend of E. coli isolates identified at a tertiary care Shalamar Hospital in Lahore, Pakistan. The frequency of E. coli isolated from different infectious sites across various age groups and their resistance proportions against CLSI-recommended antibiotics was accessed for 10 years. RESULTS: E. coli is a Gram-negative bacterium that has caused a wide range of infections, predominantly urinary tract infections, with increasing antibiotic resistance. The results indicate a resistance rate of 98% to ampicillin, 93% to amoxicillin/clavulanic acid, and 87% and 82% to second and third-generation cephalosporins: cefuroxime, cefotaxime and ceftriaxone, respectively. High susceptibility against carbapenems and polymyxins drugs was also reported. However, over 10 years, an increasing resistance trend was observed against cefuroxime and imipenem and a significant decreasing trend was observed against gentamicin and nitrofurantoin. Likewise, resistance against beta-lactam like cefotaxime, ceftriaxone, and cefuroxime significantly increased compared to imipenem and meropenem compared to mean antibiotic resistance across all age groups. CONCLUSION: It highlights the emerging resistance trend against commonly prescribed antimicrobial drugs, leading to understanding the longitudinal resistance trends of E. coli in the region.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。